Henry Shelford, CEO and Co-Founder of ADHD UK, was quoted in the article and provided background information.
The article from the Milton Keynes Citizen reports a significant increase in ADHD medication prescriptions within the NHS Bedfordshire, Luton, and Milton Keynes Integrated Care Board. In the year leading up to March 2024, 7,103 patients received prescriptions for central nervous system stimulants and other ADHD-related drugs, up from 4,939 the previous year. This marks the highest figure since records began in 2015-2016. Nationally, 278,000 patients in England were prescribed ADHD medications, a 19% increase from the prior year. Henry Shelford, Chief Executive of ADHD UK, views these numbers positively, suggesting they reflect increased assessments and support for individuals with ADHD.
You can read the full article here: https://www.miltonkeynes.co.uk/news/people/record-number-of-patients-in-milton-keynes-have-prescription-for-adhd-medication-4791071
